FIGURE 2.
The incidence of exon 19 deletion and exon 21 L858R mutation in nonsmall-cell lung cancer patients according to different age groups (A), different N-stage groups (B), and different M-stage groups (C).
The incidence of exon 19 deletion and exon 21 L858R mutation in nonsmall-cell lung cancer patients according to different age groups (A), different N-stage groups (B), and different M-stage groups (C).